Related Experiment Video
Updated: Feb 23, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Invasive Pulmonary Fungal Infections in Cystic Fibrosis
Carsten Schwarz1, Claudia Brandt2, Paul Whitaker3
1Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. carsten.schwarz@charite.de.
Abstract:
Invasive pulmonary mycosis is after allergic bronchopulmonary aspergillosis (ABPA) a frequent and severe complication of CF lung disease. Among CF caregivers, there is an insecurity when and how to treat infections of the lung parenchyma caused by different fungi in patients with CF. This case series provides a multicenter experience on diagnostic, manifestation, and treatment of non-ABPA cases of pulmonary. Non-ABPA cases of pulmonary mycoses in patients with CF have been collected from the CF Centers in Berlin, Essen, Worms, Frankfurt (Germany), Leeds (UK), and Barcelona (Spain). Non-ABPA was defined as total serum IgE level <500 kU/L. Scedosporium and Lomentospora species seem to be more virulent in patients with CF and have been successfully treated with triple antifungal drug regimens in several cases. Rare fungi including yeasts can have pathogenic potential in CF. In this series, antibiotic treatment failure was the main indicator for the initiation of antifungal treatment. For an early and effective treatment of pulmonary mycoses in CF, the identification of biomarkers and of risk factors beyond antibiotic treatment failure is crucial and urgently needed. Furthermore, treatment efficacy studies are necessary for the different causative agents of these infections.
Insights
Pulmonary mycoses, excluding allergic bronchopulmonary aspergillosis (ABPA), are serious in cystic fibrosis (CF). Early diagnosis and targeted antifungal treatment are vital for better outcomes in CF patients.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Invasive pulmonary mycosis is a frequent and severe complication in cystic fibrosis (CF) lung disease, often following allergic bronchopulmonary aspergillosis (ABPA).
- Caregivers express uncertainty regarding the diagnosis and treatment of fungal lung infections in CF patients.
- Non-ABPA pulmonary mycoses represent a significant challenge in CF management.
Purpose of the Study:
- To present a multicenter experience on the diagnosis, manifestation, and treatment of non-ABPA pulmonary mycoses in patients with CF.
- To highlight the role of specific fungal species and treatment strategies.
- To identify needs for improved diagnostic and therapeutic approaches.
Main Methods:
- A case series approach was employed, collecting data from CF centers in Germany, the UK, and Spain.
- Non-ABPA was defined by a total serum IgE level below 500 kU/L.
- Data on diagnostic methods, clinical manifestations, and treatment regimens were analyzed.
Main Results:
- Scedosporium and Lomentospora species demonstrated higher virulence in CF patients.
- Successful treatment of these infections was achieved with triple antifungal drug regimens in several instances.
- Antibiotic treatment failure was a primary indicator for initiating antifungal therapy.
Conclusions:
- Rare fungi, including yeasts, can be pathogenic in CF patients.
- Identifying biomarkers and risk factors beyond antibiotic treatment failure is crucial for early and effective management of pulmonary mycoses in CF.
- Further treatment efficacy studies are necessary for various causative agents.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

